Public health burden of antimicrobial resistance in Europe
Open Access
- 5 November 2018
- journal article
- editorial
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 19 (1), 4-6
- https://doi.org/10.1016/s1473-3099(18)30648-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysisThe Lancet Infectious Diseases, 2018
- Estimating the burden of antimicrobial resistance: a systematic literature reviewAntimicrobial Resistance & Infection Control, 2018
- Surveillance for control of antimicrobial resistanceThe Lancet Infectious Diseases, 2018
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?PLoS Medicine, 2016
- Economic burden of antibiotic resistance: how much do we really know?Clinical Microbiology & Infection, 2014
- Antibiotic resistance—the need for global solutionsThe Lancet Infectious Diseases, 2013
- The burden of infectious diseases in Europe: a pilot studyEurosurveillance, 2007